|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02480 LUZHU BIOTECH-B
Nominal 
21.300 +0.260 (+1.236%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | (86,085) | (189,948) | (77,265) | (19,165) |
| Net Cash from / (used in) Investing Activities | (47,583) | 98,581 | (223,262) | (403,997) |
| Net Cash from / (used in) Financing Activities | 14,889 | 273,171 | 336,978 | 454,991 |
| Increase / (Decrease) in Cash & Cash Equivalents | (118,779) | 181,804 | 36,451 | 31,829 |
| Cash & Cash Equivalents at beginning of period | 257,891 | 68,976 | 32,030 | 201 |
| Effect of Foreign Exchange Rate Changes | 1,014 | 7,111 | 495 | 0 |
| Others | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 140,126 | 257,891 | 68,976 | 32,030 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -77,570 |
| %Change | -29.442% |
| EPS / (LPS) | RMB -0.390 |
| NBV Per Share (¥) | RMB 3.710 |